- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
Biopharmaceutical company Seaport Therapeutics announced the appointment of Lana Gladstein as general counsel.
Most recently, Gladstein was the group general counsel at APRINOIA Therapeutics. Her prior roles include chief legal officer at Recipharm; chief legal officer and general counsel at Arranta Bio; and executive vice president, general counsel, and officer at Brammer Bio.
Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
National Philanthropic Trust announced the appointment of Tamara Watts, vice president, legal and general counsel for The Susan Thompson Buffett Foundation, to its board of trustees.
Succession Resource Group, a consulting firm specializing in wealth management business valuations, employment solutions, succession planning, and M&A transactions, announced the appointment of Todd Fulks as general counsel.
No comments yet